Cannabis News

Canopy Growth To Participate In Barclays Global Consumer Staples Virtual Conference On September 8, 2021

Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) ("Canopy Growth" or "the Company") announced today that CEO David Klein will present virtually at the 2021 Barclays Global Consumer Staples Conference on Wednesday, September 8, 2021 at 3:20pm ET . The presentation is expected to cover the company's progress against its business transformation, overview of the U.S. businesses, and key U.S. strategic business initiatives.

Canopy Growth To Participate In Barclays Global Consumer Staples Virtual Conference On September 8, 2021 (CNW Group/Canopy Growth Corporation)

The presentation will be conducted by live audio webcast, and will be accessible through the company's website at https://www.canopygrowth.com/investors/investor-events/ . A replay option will be available on the company's website for those that cannot participate in the live event.

About Canopy Growth Corporation
Canopy Growth (TSX:WEED,NASDAQ:CGC ) is a world-leading diversified cannabis and cannabinoid-based consumer product company, driven by a passion to improve lives, end prohibition, and strengthen communities by unleashing the full potential of cannabis. Leveraging consumer insights and innovation, we offer product varieties in high quality dried flower, oil, softgel capsule, infused beverage, edible, and topical formats, as well as vaporizer devices by Canopy Growth and industry-leader Storz & Bickel. Our global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both Canada and Germany . Through our award-winning Tweed and Tokyo Smoke banners, we reach our adult-use consumers and have built a loyal following by focusing on top quality products and meaningful customer relationships. Canopy Growth has entered into the health and wellness consumer space in key markets including Canada , the United States , and Europe through BioSteel sports nutrition, and This Works skin and sleep solutions; and has introduced additional hemp-derived CBD products to the United States through our First & Free and Martha Stewart CBD brands. Canopy Growth has an established partnership with Fortune 500 alcohol leader Constellation Brands. For more information visit www.canopygrowth.com .

Notice Regarding Forward Looking Statements
This press release contains "forward-looking statements" and "forward-looking information" within the meaning of applicable U.S. and Canadian securities laws (collectively, "forward-looking statements"), which involve certain known and unknown risks and uncertainties. Forward-looking statements predict or describe our future operations, business plans, business and investment strategies and the performance of our investments. These forward-looking statements are generally identified by their use of such terms and phrases as "intend," "goal," "strategy," "estimate," "expect," "project," "projections," "forecasts," "plans," "seeks," "anticipates," "potential," "proposed," "will," "should," "could," "would," "may," "likely," "designed to," "foreseeable future," "believe," "scheduled" and other similar expressions. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made. Forward–looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those forward–looking statements and the forward–looking statements are not guarantees of future performance. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. A discussion of some of the material factors applicable to Canopy Growth Corporation ("Canopy") can be found under the section entitled "Risk Factors" in Canopy's Annual Report on Form 10-K for the year ended March 31, 2021, filed with the Securities and Exchange Commission and with applicable Canadian securities regulators, as such factors may be further updated from time to time in its periodic filings with the Securities and Exchange Commission and with applicable Canadian securities regulators, which can be accessed at www.sec.gov/edgar and www.sedar.com , respectively. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this press release and in the filings. Any forward–looking statement included in this press release is made as of the date of this press release and, except as required by law, Canopy disclaims any obligation to update or revise any forward–looking statement. Readers are cautioned not to put undue reliance on any forward–looking statement. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/canopy-growth-to-participate-in-barclays-global-consumer-staples-virtual-conference-on-september-8-2021-301363090.html

SOURCE Canopy Growth Corporation

News Provided by PR Newswire via QuoteMedia

The Conversation (0)

Trulieve Announces Over 965,000 Signatures for Florida's Smart & Safe Campaign

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States today announced the Florida Secretary of State has validated over 965,000 signatures for the Smart & Safe Florida campaign's drive to bring adult use cannabis to Florida . That number represents more than enough to secure ballot placement for the 2024 General Election.

Trulieve logo (PRNewsfoto/Trulieve Cannabis Corp.)

The initiative, if passed, will allow adult Floridians (ages 21+) to enjoy the freedom to use cannabis products for personal consumption.

Trulieve CEO, Kim Rivers said, "Our investment demonstrates our firm belief that Floridians are ready to experience the freedom to use cannabis for personal consumption; a freedom which is currently enjoyed by more than half of America's adults. With over 965,000 validated signatures from nearly every part of our state, it is clear these voters share that belief. We are thrilled the campaign has made this milestone and look forward to seeing this initiative on the ballot next November."

The next step for the campaign will be to seek approval from the Florida Supreme Court, as required by Florida law and the State Constitution, to ensure the ballot language addresses only one subject and clearly states the chief purpose of the amendment.

Rivers added, "We believe the language, as written, comports with the single subject and clarity requirements under Florida law and look forward to a positive ruling from the Court."

The Florida Supreme Court has published a schedule to begin that process with briefs due from opponents by June 12th and from supporters by July 5th . All amendments to the Florida Constitution must receive 60% of the vote and most published polls show this initiative consistently cresting above 65% among likely Florida voters.

About Trulieve

Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S. operating in 11 states, with leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com .

Facebook: @Trulieve
Instagram: @Trulieve_
Twitter: @Trulieve

Investor Contact
Christine Hersey , Vice President of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Media Contact
Nicole Yelland , Executive Director of Corporate Communications
+1 (248) 219-9234
Nicole.Yelland@Trulieve.com

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/trulieve-announces-over-965-000-signatures-for-floridas-smart--safe-campaign-301840424.html

SOURCE Trulieve Cannabis Corp.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2023/01/c8408.html

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Cronos Group Announces Streamlined Operating Structure to Improve Cash Flow

Plans to Exit Existing U.S. hemp-derived CBD Operations

Intends to Launch Lord Jones ® Brand in the Canadian Adult-use Market in Q4 2023

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Cronos Group Inc. to Speak at Bernstein's 39th Annual Strategic Decisions Conference

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company"), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at Bernstein's 39th Annual Strategic Decisions Conference on Thursday, June 1, 2023, at 1:30PM ET.

A live webcast will be available on the Investors section of the Company's website at https://ir.thecronosgroup.com/events-presentations .

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
phone showing canadian competition bureau website

Cannabis Weekly Round-Up: Canadian Competition Bureau Calls for Industry Changes

The Canadian cannabis industry needs new THC limits and more relaxed promotional rules in order to thrive, a federal agency said this week in a new report. It also recommends a review of the licensing process.

Meanwhile, a leading multi-state operator enjoyed a jump in share value thanks to its most recent financial report.

Keep reading to find out more cannabis highlights from the past five days.

Keep reading...Show less

Goodness Growth Holdings and Grown Rogue International Announce Strategic Advisory Agreement

Goodness Growth engages Grown Rogue to prioritize improved quality and productivity of its cultivation operations –

– Agreement unites Grown Rogue's cultivation expertise with Goodness Growth's footprint and commitment to its customers for accessible, quality cannabis products –

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Creso Pharma

Wholly-Owned Subsidiary, Mernova Medicinal Inc. Continues Strong Progress In Q2 Securing C$593,926 In New Purchase Orders During May

Creso Pharma Limited (ASX:CPH, FRA:1X8) (‘Creso Pharma’ or ‘the Company’) is pleased to provide the following update on progress through wholly-owned Canadian subsidiary, Mernova Medicinal Inc. (‘Mernova’), which has continued to achieve strong growth in purchase orders in May, as well as an extension of licenses with Health Canada and Canada Revenue Agency.

Keep reading...Show less

Latest Press Releases

Related News

×